← All companies
CSCI
COSCIENS Biopharma Inc.
$5.14
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$16.4M
Revenue (TTM)
—
Net income (TTM)
—
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
—
Total assets
—
Gross margin
—
52-week range
$2.37 – $12.12
Recent SEC filings
40 most recentAnnual, quarterly & current reports
6-K
Jul 6, 2026
6-K
Jun 23, 2026
6-K
Jun 18, 2026
6-K
May 20, 2026
6-K
May 12, 2026
6-K
May 12, 2026
6-K
May 8, 2026
6-K
Apr 20, 2026
6-K
Apr 7, 2026
20-F
Mar 25, 2026
6-K
Mar 25, 2026
6-K
Mar 5, 2026
6-K
Feb 13, 2026
6-K
Dec 1, 2025
6-K
Nov 14, 2025
6-K
Nov 12, 2025
6-K
Nov 12, 2025
6-K
Aug 14, 2025
6-K
Aug 14, 2025
6-K
Jun 30, 2025
6-K
Jun 9, 2025
6-K
Jun 2, 2025
6-K
May 30, 2025
6-K
May 27, 2025
6-K
May 20, 2025
6-K
May 13, 2025
6-K
May 13, 2025
6-K
May 2, 2025
6-K
Apr 14, 2025
20-F
Apr 9, 2025
6-K
Apr 9, 2025
6-K
Apr 2, 2025
6-K
Mar 20, 2025
6-K
Mar 13, 2025
6-K
Dec 23, 2024
6-K
Nov 12, 2024
6-K
Nov 12, 2024
6-K
Oct 8, 2024
6-K
Oct 1, 2024
6-K
Sep 23, 2024